These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6126072)

  • 1. Plasma lipids and lipoproteins in long-term beta-adrenergic blockade.
    Jürgensen HJ; Meinertz H; Faergeman O
    Acta Med Scand; 1982; 211(6):449-52. PubMed ID: 6126072
    [No Abstract]   [Full Text] [Related]  

  • 2. The long-term effect of alprenolol on plasma apolipoproteins A-I and B.
    Gerdes LU; Jürgensen HJ; Groot PH; Faergeman O
    Acta Med Scand; 1988; 223(5):419-22. PubMed ID: 3132028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
    Frishman WH
    Am Heart J; 1980 Apr; 99(4):528-36. PubMed ID: 6102436
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1979 Dec; 21(25):101. PubMed ID: 44732
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL
    Wien Med Wochenschr; 1982; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction.
    Ghosh P; Cochrane AM; de Bono D
    Lancet; 1975 Jan; 1(7897):9-10. PubMed ID: 46384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Background and aims of the study.
    Jürgensen HJ
    Acta Med Scand Suppl; 1984; 680():4-7. PubMed ID: 6375279
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Study design, patient characteristics and conduct of the study.
    Jürgensen HJ; Andersen MP; Bechsgaard P; Frederiksen J; Hansen DA; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Acta Med Scand Suppl; 1984; 680():8-17. PubMed ID: 6375283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reduction of mortality in acute myocardial infarction in patients treated with alprenolol. Preliminary results].
    Andersen M; Bechsgaard P; Frederiksen J; Hansen DA; Jürgensen HJ; Nielsen PB; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3083-6. PubMed ID: 43001
    [No Abstract]   [Full Text] [Related]  

  • 10. Postinfarction therapy with beta blockers: who should be treated?
    Moss AJ
    Int J Cardiol; 1982; 1(5-6):343-9. PubMed ID: 6126440
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins.
    Kristensen BO
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):191-2. PubMed ID: 6114770
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of long term beta-blockade after myocardial infarction: Paper 3.
    Wilkinson RK
    Aust Fam Physician; 1978 Jun; Suppl():38-9. PubMed ID: 30443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of beta blockers for the reduction of mortality after myocardial infarction.
    Hampton JR
    Eur Heart J; 1981 Aug; 2(4):259-68. PubMed ID: 6117465
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of propranolol on blood lipids and lipoproteins in myocardial infarction.
    Shulman RS; Herbert PN; Capone RJ; McClure D; Hawkins CM; Henderson LO; Saritelli A; Campbell J
    Circulation; 1983 Jun; 67(6 Pt 2):I19-21. PubMed ID: 6851036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experiences with acute beta blockade in acute myocardial infarction].
    Pedersen F; Bechsgaard P; Nielsen PB; Rasmussen SL
    Ugeskr Laeger; 1979 Nov; 141(45):3086-9. PubMed ID: 43002
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
    Fanchamps A
    Nouv Presse Med; 1978 Sep; 7(31):2741-5. PubMed ID: 30954
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory analyses during two years' treatment with alprenolol in patients with myocardial infarction.
    Wilhelmsson C; Vedin A
    Acta Med Scand Suppl; 1975; 575():31-5. PubMed ID: 168738
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Causes of death and post-mortem findings with special reference to early deaths.
    Hansen DA; Jürgensen HJ; Pedersen-Bjergaard O
    Acta Med Scand Suppl; 1984; 680():50-8. PubMed ID: 6375281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.